loadpatents
name:-0.045166015625
name:-0.037284851074219
name:-0.00069403648376465
Drucker; Daniel J. Patent Filings

Drucker; Daniel J.

Patent Applications and Registrations

Patent applications and USPTO patent grants for Drucker; Daniel J..The latest application filed is for "method of regulating glucose metabolism, and reagents related thereto".

Company Profile
0.30.26
  • Drucker; Daniel J. - Toronto CA
  • Drucker; Daniel J - Toronto N/A CA
  • Drucker; Daniel J. - Ontariio CA
  • Drucker, Daniel J. - Ontario CA
*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.
Patent Activity
PatentDate
Method of Regulating Glucose Metabolism, and Reagents Related Thereto
App 20160000857 - Bachovchin; William W. ;   et al.
2016-01-07
Methods for treating disorders of the gastrointestinal tract using a GLP-1 agonist
Grant 9,168,288 - Drucker , et al. October 27, 2
2015-10-27
Methods Of Enhancing Functioning Of The Large Intestine
App 20150290295 - Drucker; Daniel J.
2015-10-15
Methods of regulating glucose metabolism, and reagents related thereto
Grant 9,044,424 - Bachovchin , et al. June 2, 2
2015-06-02
Glucagon-like peptide-2 analogs
Grant 8,933,039 - Drucker , et al. January 13, 2
2015-01-13
Glucagon-like peptide-2 analogs
Grant 8,846,625 - Drucker , et al. September 30, 2
2014-09-30
Methods Of Enhancing Functioning Of The Large Intestine
App 20140213518 - Drucker; Daniel J.
2014-07-31
Methods of Regulating Glucose Metabolism, and Reagents Related Thereto
App 20140178472 - Bachovchin; William W. ;   et al.
2014-06-26
Methods of enhancing functioning of the large intestine
Grant 8,603,976 - Drucker December 10, 2
2013-12-10
Method of regulating glucose metabolism, and reagents related thereto
Grant 8,513,190 - Bachovchin , et al. August 20, 2
2013-08-20
Glucagon-like Peptide-2 Analogs
App 20130203673 - Drucker; Daniel J. ;   et al.
2013-08-08
Methods for Treating Disorders of the Gastrointestinal Tract Using a GLP-1 Agonist
App 20130053316 - Drucker; Daniel J. ;   et al.
2013-02-28
Methods Of Enhancing Functioning Of The Large Intestine
App 20120328527 - Drucker; Daniel J.
2012-12-27
Method of regulating glucose metabolism, and reagents related thereto
Grant 8,318,669 - Bachovchin , et al. November 27, 2
2012-11-27
Methods of enhancing functioning of the large intestine
Grant 8,278,273 - Drucker October 2, 2
2012-10-02
Method of Regulating Glucose Metabolism, and Reagents Related Thereto
App 20120165252 - Bachovchin; William W. ;   et al.
2012-06-28
Methods Of Enhancing Functioning Of The Large Intestine
App 20110275568 - Drucker; Daniel J.
2011-11-10
Glucagon-like Peptide-2 And Its Therapeutic Use
App 20110223108 - Drucker; Daniel J.
2011-09-15
Methods of enhancing functioning of the large intestine
Grant 7,960,344 - Drucker June 14, 2
2011-06-14
Glucagon-like peptide-2 and its therapeutic use
Grant 7,888,317 - Drucker February 15, 2
2011-02-15
Glucagon-like Peptide-2 Analogs
App 20110009320 - Drucker; Daniel J. ;   et al.
2011-01-13
Enhancement of GLP-2 activity of suppressing appetite
Grant 7,862,824 - Drucker , et al. January 4, 2
2011-01-04
Glucagon-like peptide-2 analogs
Grant 7,781,401 - Drucker , et al. August 24, 2
2010-08-24
Methods Of Enhancing Functioning Of The Large Intestine
App 20100119453 - Drucker; Daniel J.
2010-05-13
Methods of enhancing functioning of the large intestine
Grant 7,642,241 - Drucker January 5, 2
2010-01-05
Methods of enhancing functioning of the large intestine
App 20070129304 - Drucker; Daniel J.
2007-06-07
Methods of enhancing functioning of the large intestine
Grant 7,176,182 - Drucker February 13, 2
2007-02-13
GLP-2 receptor gene promoter and uses thereof
App 20070033662 - Drucker; Daniel J. ;   et al.
2007-02-08
Glucagon-like peptide-2 and its therapeutic use
Grant 7,049,284 - Drucker May 23, 2
2006-05-23
Glucagon-like peptide-2 and its therapeutic use
App 20060105954 - Drucker; Daniel J.
2006-05-18
Enhancement of GLP-2 activity
App 20040198642 - Drucker, Daniel J. ;   et al.
2004-10-07
Ampk-related serine/threonine kinase, designated snark
App 20040132025 - Drucker, Daniel J. ;   et al.
2004-07-08
Polynucleotides encoding proexendin, and methods and uses thereof
Grant 6,723,530 - Drucker April 20, 2
2004-04-20
Methods of enhancing functioning of the large intestine
App 20030207809 - Drucker, Daniel J.
2003-11-06
Glucagon-like peptide-2 analogs
App 20030162703 - Drucker, Daniel J. ;   et al.
2003-08-28
Glucagon-like peptide-2 and its therapeutic use
App 20030158101 - Drucker, Daniel J.
2003-08-21
Methods of enhancing functioning of the large intestine
Grant 6,586,399 - Drucker July 1, 2
2003-07-01
Antagonists of intestinotrophic GLP-2 peptides
App 20030109449 - Drucker, Daniel J. ;   et al.
2003-06-12
Chemotherapy treatment
App 20030040478 - Drucker, Daniel J ;   et al.
2003-02-27
Antagonists of intestinotrophic GLP-2 peptides
Grant 6,489,295 - Drucker , et al. December 3, 2
2002-12-03
Enhancement of GLP-2 activity
App 20020123461 - Drucker, Daniel J. ;   et al.
2002-09-05
GLP-2 receptor gene promoter and uses thereof
App 20020045173 - Drucker, Daniel J. ;   et al.
2002-04-18
Methods of enhancing functioning of the large intestine
Grant 6,297,214 - Drucker October 2, 2
2001-10-02
Glucagon-like peptide-2 analogs
App 20010021767 - Drucker, Daniel J. ;   et al.
2001-09-13
Intestinotrophic glucagon-like peptide-2 analogs
Grant 6,184,201 - Drucker , et al. February 6, 2
2001-02-06
Methods of enhancing functioning of the upper gastrointestinal tract
Grant 6,051,557 - Drucker April 18, 2
2000-04-18
Antagonists of intestinotrophic GLP-2 peptides
Grant 5,994,500 - Drucker , et al. November 30, 1
1999-11-30
Glucagon-like peptide-2 and its therapeutic use
Grant 5,990,077 - Drucker November 23, 1
1999-11-23
Method of using exendin and GLP-1 to affect the central nervous system
Grant 5,846,937 - Drucker December 8, 1
1998-12-08
Glucagon-like peptide-2 and its therapeutic use
Grant 5,834,428 - Drucker November 10, 1
1998-11-10
Glucagon-like peptide-2 analogs
Grant 5,789,379 - Drucker , et al. August 4, 1
1998-08-04

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.

© 2024 USPTO.report | Privacy Policy | Resources | RSS Feed of Trademarks | Trademark Filings Twitter Feed